Maria Descartes
Clinical Genetics (M.D.) · Fort Myers, FLNPI 1841233988
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,277 of the $8,678 with a category attached, or 95.4%. Sanofi accounts for 71.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $4,843 and has fallen 98.8% since, to $58 in 2024.
Across 15 payments — averaging $578.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$6K
- Amgen$2K
- Sanofi-aventis U.S. LLC$450
- Biomarin Pharmaceutical Inc.$125
- Takeda Pharmaceuticals U.S.A., Inc.$40
- Alnylam Pharmaceuticals Inc.$26
- plus $56 from 3 others
What the payments were for
- Speaking & faculty fees$8,27795%
- Travel & lodging$2583%
- Food & beverage$1432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $6,164 |
| Amgen | 2 | $1,818 |
| Sanofi-aventis U.S. LLC | 1 | $450 |
| Biomarin Pharmaceutical Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Merck | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,678 in reported general payments places this provider in the 80th percentile of 37 clinical genetics (m.d.) providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Fort Myers
- Christopher GriffithFort Myers$49
- Roberto ZoriGainesville$169K
- Amarilis Sanchez ValleTampa$166K
- Paldeep AtwalWest Palm Beach$121K
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Ingrid CristianOrlando$38K
- Klaas WierengaGainesville$5K
- Irman ForghaniMiami$3K
- Sajel LalaMiami$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.